Martine Rothblatt Insider Profile

4 Followers
Martine Rothblatt, Chairperson & CEO, Director at United Therapeutics, holds 644.49K shares in United Therapeutics (Ticker: UTHR).
tipranks
Martine Rothblatt

Martine Rothblatt
United Therapeutics (UTHR)
Chairperson & CEO, Director

Ranked #62,184 out of 99,172 Corporate Insiders

Profitable Transactions

50%
7 out of 14 Profitable Transactions

Average Return

-4.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$225M
100.00%
A breakdown of Martine Rothblatt's holdings

Insider Roles

United Therapeutics
(UTHR)
Chairperson & CEO, Director
Roles that Martine Rothblatt holds in companies

Most Profitable Insider Trade

Stock:
United Therapeutics
(UTHR)
Rating:Informative Sell
Date:Jun 03, 2015 - Jun 03, 2016
Return:+36.70%
The most profitable trade made by Martine Rothblatt

Martine Rothblatt's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
United Therapeutics
Aug 28, 2024
Chairperson & CEO, Director
Uninformative Buy
34.83K
$225.38M
Success Rate for
UTHR
7 out of 14 profitable transactions on
UTHR
50%
Average Return for
UTHR
Average return per transaction on
UTHR
-4.09%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 19, 2012
Uninformative Buy
$198.33K
-
$47.93
Jun 20, 2012
Uninformative Buy
$189.88K
-
$47.95
Jun 15, 2012
Uninformative Buy
$198.64K
-
$46.96
Jun 18, 2012
Uninformative Buy
$198.20K
-
$47.99
Jun 11, 2009
Informative Buy
$3.32M
-
$85.04
List of latest transactions for each holding click on a transaction to see Martine Rothblatt's performance on stock

Martine Rothblatt insider profile FAQ

What is the percentage of profitable transactions made by Martine Rothblatt?
The percentage of profitable transactions made by Martine Rothblatt is 50%.
    What is the average return per transaction made by Martine Rothblatt?
    The average return per transaction made by Martine Rothblatt is -4.00%.
      What stocks does Martine Rothblatt hold?
      Martine Rothblatt holds: UTHR stocks.
        What was Martine Rothblatt’s latest transaction?
        Martine Rothblatt latest transaction was an Uninformative Buy of $34.83K.
          What was Martine Rothblatt's most profitable transaction?
          Martine Rothblatt’s most profitable transaction was an Informative Sell of UTHR stock on June 3, 2015. The return on the trade was 36.70%.
            What is Martine Rothblatt's role in United Therapeutics?
            Martine Rothblatt's role in United Therapeutics is Chairperson & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.